Top

Sleep and Breathing

Published in:

Open Access 01-08-2009 | Original Article

The roles of TNF-α and the soluble TNF receptor I on sleep architecture in OSA

Authors: Herbert J. Yue, Paul J. Mills, Sonia Ancoli-Israel, José S. Loredo, Michael G. Ziegler, Joel E. Dimsdale

Published in: Sleep and Breathing | Issue 3/2009

Abstract

Objective

Patients with obstructive sleep apnea (OSA) have been described to have increased levels of inflammatory cytokines (particularly TNF-α) and have severely disturbed sleep architecture. Serum inflammatory markers, even in normal individuals, have been associated with abnormal sleep architecture. Not much is known about the role the TNF receptor plays in the inflammation of OSA nor if it is associated with changes in sleep architecture or arousals during the night. We hypothesized that the TNF receptor might play an important role in the inflammation as well as sleep architecture changes in patients with OSA.

Design

Thirty-six patients with diagnosed (AHI > 15) but untreated OSA were enrolled in this study. Baseline polysomnograms as well as TNF-α and soluble TNF receptor I (sTNF-RI) serum levels were obtained on all patients. We evaluated the association between serum levels of TNF-α and sTNF-RI with various polysomongraphic characteristics, including sleep stages and EEG arousals.

Results

sTNF-RI levels were significantly correlated with snore arousals (r value 0.449, p value 0.009), spontaneous movement arousals (r value 0.378, p value 0.025), and periodic limb movement arousals (r value 0.460, p value 0.008). No statistically significant correlations were observed with TNF-α to any polysomnographic variables. To control for statistical significance with multiple comparisons, a MANOVA was performed with TNF-α and sTNF-RI as dependent variables and sleep architecture measures and arousals as independent variables. The model for sTNF-RI was statistically significant (F value 2.604, p value 0.03), whereas the model for TNF-α was not, suggesting sleep quality significantly affects sTNF-RI. Hierarchal linear regression analysis demonstrated that sTNF-RI was independently associated with spontaneous movement arousal index scores after controlling for age, body mass index, and sleep apnea severity.

Conclusions

These findings suggest that sTNF-RI is associated with arousals during sleep, but not with other measures in patients with OSA.

Young T, Skatrud J, Peppard PE (2004) Risk factors for obstructive sleep apnea in adults. JAMA 291:2013–2016. doi:10.1001/jama.291.16.2013 PubMedCrossRef

Sekosan M, Zakkar M, Wenig BL, Olopade CO, Rubenstein I (1996) Inflammation in the uvula mucosa of patients with obstructive sleep apnea. Laryngoscope 106:1018–1020. doi:10.1097/00005537-199608000-00021 PubMedCrossRef

Bergeron C, Kimoff J, Hamid Q (2005) Images in allergy and immunology: obstructive sleep apnea syndrome and inflammation. J Allergy Clin Immunol 116:1393–1396. doi:10.1016/j.jaci.2005.10.008 PubMedCrossRef

Ursavaş A, Karadağ M, Rodoplu E, Yilmaztepe A, Oral HB, Gözü RO (2007) Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 74:525–532. doi:10.1159/000097770 PubMedCrossRef

von Känel R, Loredo JS, Ancoli-Israel S, Mills PJ, Natarajan L, Dimsdale JE (2007) Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest 131:733–739. doi:10.1378/chest.06-2006 CrossRef

Punjabi NM, Beamer BA (2007) C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 30:29–34PubMed

de la Pena Bravo M, Serpero LD, Barcelo A et al (2007) Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breath 11:177–185. doi:10.1007/s11325-007-0100-7 CrossRef

Minoguchi K, Tazaki T, Yokoe T et al (2004) Elevated production of tumor necrosis factor-α by monocytes in patients with obstructive sleep apnea syndrome. Chest 126:1473–1479. doi:10.1378/chest.126.5.1473 PubMedCrossRef

Ciftci TU, Korturk O, Bukan N et al (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28:87–91. doi:10.1016/j.cyto.2004.07.003 PubMedCrossRef

10.

Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82:1313–1316. doi:10.1210/jc.82.5.1313 PubMedCrossRef

11.

Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Endocrinol Metab 85:1151–1158. doi:10.1210/jc.85.3.1151 CrossRef

12.

Aderka D (1996) The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7:231–240. doi:10.1016/S1359-6101(96)00026-3 PubMedCrossRef

13.

Brockhaus M, Schoenfeld H, Schlaeger E, Hunziker W, Lesslauer W, Loetscher H (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127–3131. doi:10.1073/pnas.87.8.3127 PubMedCrossRef

14.

ElBarbary MKKS, ElBarbary M, Khabar K (2002) Soluble tumor necrosis factor receptor p55 predicts cytokinemia and systemic inflammatory response after cardiopulmonary bypass. Crit Care Med 30:1712–1716. doi:10.1097/00003246-200208000-00006 CrossRef

15.

Hensler T, Sauerland S, Bouillion B, Raum M, Rixen D, Helling H, Andermahr J, Neugebauer E (2002) Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase. J Trauma 52:962–970. doi:10.1097/00005373-200205000-00023 PubMedCrossRef

16.

Pittet J, Mackersie R, Martin T, Matthay M (1997) Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155:1187–1205PubMed

17.

Parsons PE, Matthay MA, Ware LB, Eisner MD, National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network (2005) Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 288:L426–L431. doi:10.1152/ajplung.00302.2004 PubMedCrossRef

18.

Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, Bruno F, Slutsky AS (1999) Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 282:54–61. doi:10.1001/jama.282.1.54 PubMedCrossRef

19.

Hyers T, Tricomi SM, Dettenmeier P, Fowler A (1991) Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am Rev Respir Dis 144:268–271PubMed

20.

Parsons P, Moore F, Moore E, Ikle D, Henson P, Worthen G (1992) Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis 146:694–700PubMed

21.

Mills PJ, von Känel R, Norman D, Natarajan L, Ziegler MG, Dimsdale JE (2007) Inflammation and sleep in healthy individuals. Sleep 30:729–735PubMed

22.

Darko DF, Miller JC, Gallen C, White J, Koziol J, Brown SJ, Hayduk R, Atkinson JH, Assmus J, Munnell DT, Naitoh P, McCutchan JA, Mitler MM (1995) Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection. Proc Natl Acad Sci USA 92:12080–12084. doi:10.1073/pnas.92.26.12080 PubMedCrossRef

23.

Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–1904. doi:10.1172/JCI118235 PubMedCrossRef

24.

Narkiewica K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK (1998) Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98:772–776

25.

Loredo JS, Ziegler MG, Ancoli-Israel S, Clausen JL, Dimsdale JE (1999) Relationship of arousals from sleep to sympathetic nervous system activity and BP in obstructive sleep apnea. Chest 116:655–659. doi:10.1378/chest.116.3.655 PubMedCrossRef

26.

Rechtshaffen A, Kales A (1968) A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. National Institute of Health Publication 204: US Government Printing Office Washington, DC

27.

Report ASDA (1992) EEG arousals: scoring rules and examples. Sleep 15:174–184

28.

Loredo JS, Clausen JL, Ancoli-Israel S, Dimsdale JE (1999) Night-to-night arousal variability and interscorer reliability of arousal measurements. Sleep 22:916–920PubMed

29.

Fang J, Wang Y, Krueger JM (1997) Mice lacking the TNF 55 kDa receptor fail to sleep more after TNF-alpha treatment. J Neurosci 17:5949–5955PubMed

30.

Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF (2001) Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 107:165–170. doi:10.1067/mai.2001.112270 PubMedCrossRef

31.

Kataoka T, Enomoto F, Kim R, Yokoi H, Fujimori M, Sakai Y, Ando I, Ichikawa G, Ikeda K (2004) The effect of surgical treatment of obstructive sleep apnea syndrome on the plasma TNF-alpha levels. Tohoku J Exp Med 204:267–272. doi:10.1620/tjem.204.267 PubMedCrossRef

32.

Phillips CL, Yang Q, Williams A, Roth M, Yee BJ, Hedner JA, Berend N, Grunstein RR (2007) The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res 16:217–225. doi:10.1111/j.1365-2869.2007.00589.x PubMedCrossRef

33.

Alberti A, Sarchielli P, Gallinella E et al (2003) Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 12:305–311PubMed

34.

Kobayashi K, Nishimura Y, Shimada T, Yoshimura S, Funada Y, Satouchi M, Yokoyama M (2006) Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest 129:632–637. doi:10.1378/chest.129.3.632 PubMedCrossRef

35.

Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660–2667. doi:10.1161/CIRCULATIONAHA.105.556746 PubMedCrossRef

36.

Dickstein JB, Moldofsky H, Lue FA, Hay JB (1999) Intracerebroventricular injection of TNF-alpha promotes sleep and is recovered in cervical lymph. Am J Physiol 276:R1018–R1022PubMed

Title: The roles of TNF-α and the soluble TNF receptor I on sleep architecture in OSA
Authors: Herbert J. Yue
Paul J. Mills
Sonia Ancoli-Israel
José S. Loredo
Michael G. Ziegler
Joel E. Dimsdale
Publication date: 01-08-2009
Publisher: Springer-Verlag
Published in: Sleep and Breathing / Issue 3/2009
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-008-0242-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Design

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2009

Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin

Symptoms and risk of obstructive sleep apnea in primary care patients in Jordan

BMI is an independent risk factor for snoring in Chinese women aged over 30 years

American Academy of Dental Sleep Medicine Continuing Education Offerings

Utility of split-night polysomnography in the diagnosis of upper airway resistance syndrome

Comment on the article “Prevalence of probable obstructive sleep apnea risk and severity in a population of dental patients” by D.J. Levendowski et al.

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials